Clearmind Medicine to Feature New Insights from CMND-100 Psychedelic Clinical Trial on “Inside MEAI” Webinar
Go back to Clearmind Medicine to Feature New Insights from CMND-100 Psychedelic Clinical Trial on “Inside MEAI” Webinar| (NASDAQ: CMND) | Delayed: 2.50 -0.18 (6.72%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.68 | 52 Week High | $ | |||
| Open | $2.64 | 52 Week Low | $ | |||
| Day High | $2.68 | P/E | N/A | |||
| Day Low | $2.50 | EPS | $ | |||
| Volume | 57,340 | |||||
